Skip to main content

Table 1 Clinical characteristics of subjects in this study

From: The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease

 

Nonsmoker

Smoker

COPD

Subjects

16

36

42

Age yrs

58.6 ± 2.2

60.2 ± 1.1

63.7 ± 1.2

Male

16(100%)

36(100%)

42(100%)

Smoking index p.y

0

47.8 ± 4.3

48.6 ± 4.0

BMI kg/m2

23.1 ± 0.5

23.0 ± 0.3

22.1 ± 0.3

FVC % pred

108.3 ± 3.5

114.2 ± 2.5

90.6 ± 2.8**

FEV1/FVC%

81.0 ± 1.3

77.3 ± 1.0

52.0 ± 2.0**

FEV1% pred

109.7 ± 3.2

109.2 ± 2.6

61.1 ± 3.5**

  1. Values are numbers (%) or mean ± SEM; COPD Chronic Obstructive Pulmonary Disease, p.y pack-yrs, BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume in 1 sec, % pred % predicted; **: P < 0.01 versus nonsmoker and smoker